In its weekly yellow fever situation report, the World Health Organization (WHO) today noted 73 more cases of the disease in Angola, bringing that country's suspected cases to 3,625.
The US Food and Drug Administration (FDA) has expanded the age indication for Pfizer's Prevnar 13, the pneumococcal 13-valent conjugate vaccine, allowing its use in adults ages 18 through 49 years old, the company said yesterday in a press release.
Utah health officials today announced the first known Zika death in the continental United States, in a Salt Lake County resident who died in late June.
US health officials and their Liberian counterparts today announced the launch of a study to assess if a new antiviral drug can cut lingering Ebola virus RNA levels in the semen of men who survived the disease, a strategy that could decrease the risk of sexual spread.
Lessons learned can improve Zika response and US readiness for the next threat, experts said.
Patients with severe disease had high viral levels and extreme immune-system overreaction that led to destruction of healthy tissues.
A study published in the July issue of The Lancet Global Health notes that weakness, fever, distress, and diarrhea were common symptoms in children under the age of 5 years who were being treated for Ebola virus disease (EVD) in West Africa, and many presented without a fever.
The MCR-1 resistance gene, which has now been detected in at least 20 countries and renders bacteria resistant to the last-resort antibiotic colistin, poses a "substantial public health risk" to the European Union and must be combatted on a range of fronts, the European Centre for Disease Prevention and Control (ECDC) said today in its latest rapid risk assessment.
Federal officials have detected the MCR-1 resistance gene in another Escherichia coli isolate taken from a pig, bringing to three the number of US detections in 3 weeks, after the gene was found in late May in samples from a person and a separate pig.
Low doses of the Makona strain of Ebola failed to cause disease, tissue lesions, or high viral titers in macaques when administered via the mouth or eye, according to a study yesterday in the Journal of Infectious Disease.
